H.R. 946 — North American Prescription Price Equity Act of 2001

Summary

North American Prescription Price Equity Act of 2001 - Amends the Internal Revenue Code to allow drug manufacturers a limited tax credit if they certify that the wholesale price of a drug in the United States market is not greater than its wholesale price in the Canadian or Mexican market.

Full Text

Legislative Actions

2001-03-08
Introduced in House
2001-03-08
Introduced in House
2001-03-08
Sponsor introductory remarks on measure. (CR E317)
2001-03-08
Referred to the House Committee on Ways and Means.

North American Prescription Price Equity Act of 2001

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill